Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eileen L. Liao
Observed names:
E. Liao,
Eileen Liao,
Liao, Eileen
Observed institutions:
Biogen (United States),
University of Miami,
University of California, Los Angeles,
Georgetown University,
Moderna Therapeutics (United States),
Takeda Oncology (United States)
show all 6
ORCID:
0000-0001-6217-5621
Observed ORCID:
0000-0001-6217-5621
OpenAlex ID:
A5041742828
Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study
2014
·
Shaji K Kumar
, Jesus G Berdeja
, et al.
·
The Lancet Oncology
·
263
Changes in Retinal Sensitivity Associated With Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa With RPGR Gene Variations
2023
·
Lenore von Krusenstiern
, Jiajun Liu
, et al.
·
JAMA Ophthalmology
·
67
PDF
Autologous Fat Transplantation in the Craniofacial Patient
2012
·
Alan A. Lim
, Kenneth Fan
, et al.
·
Journal of Craniofacial Surgery
·
62
Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance
2019
·
Shaji K. Kumar
, Jesus G. Berdeja
, et al.
·
Leukemia
·
49
PDF
CXCR3 Chemokine Ligands During Respiratory Viral Infections Predict Lung Allograft Dysfunction
2011
·
S.S. Weigt
, A. Derhovanessian
, et al.
·
American Journal of Transplantation
·
47
Evaluation of Plastic Surgery Training Programs
2012
·
Jason Roostaeian
, Kenneth L. Fan
, et al.
·
Plastic & Reconstructive Surgery
·
46
Microvascular Autologous Breast Reconstruction in the Context of Radiation Therapy
2013
·
Ketan M. Patel
, Frank Albino
, et al.
·
Plastic & Reconstructive Surgery
·
42
Protection against Bronchiolitis Obliterans Syndrome Is Associated with Allograft CCR7+CD45RA− T Regulatory Cells
2010
·
Aric L. Gregson
, Aki Hoji
, et al.
·
PLoS ONE
·
40
PDF
Twice‐weekly ixazomib in combination with lenalidomide‐dexamethasone in patients with newly diagnosed multiple myeloma
2018
·
Paul G. Richardson
, Craig C. Hofmeister
, et al.
·
British Journal of Haematology
·
34
PDF
Protection of the Temporomandibular Joint during Syndromic Neonatal Mandibular Distraction using Condylar Unloading
2012
·
Kenneth Fan
, Brian T. Andrews
, et al.
·
Plastic & Reconstructive Surgery
·
32
Twice-Weekly Oral MLN9708 (Ixazomib Citrate), An Investigational Proteasome Inhibitor, In Combination With Lenalidomide (Len) and Dexamethasone (Dex) In Patients (Pts) With Newly Diagnosed Multiple Myeloma (MM): Final Phase 1 Results and Phase 2 Data
2013
·
Paul G. Richardson
, Craig C Hofmeister
, et al.
·
Blood
·
31
Long-Term Ixazomib Maintenance Is Tolerable and Improves Depth of Response Following Ixazomib-Lenalidomide-Dexamethasone Induction in Patients (Pts) with Previously Untreated Multiple Myeloma (MM): Phase 2 Study Results
2014
·
Shaji Kumar
, Jesus G. Berdeja
, et al.
·
Blood
·
27
Beta-blocker management of refractory hemoptysis in cystic fibrosis: a novel treatment approach
2013
·
John Moua
, Eliezer Nussbaum
, et al.
·
Therapeutic Advances in Respiratory Disease
·
13
High-Frequency Oscillatory Ventilation in Pediatric Acute Hypoxemic Respiratory Failure: Disease-Specific Morbidity Survival Analysis
2012
·
Christopher J. Babbitt
, Michael C. Cooper
, et al.
·
Lung
·
10
PDF
Hyperglycemia Is Associated With Intracranial Injury in Children Younger Than 3 Years of Age
2013
·
Christopher J. Babbitt
, Rebekah Halpern
, et al.
·
Pediatric Emergency Care
·
9
Two phase 3 studies of the oral proteasome inhibitor (PI) ixazomib for multiple myeloma (MM) in the maintenance setting: TOURMALINE-MM3, and -MM4.
2016
·
Antonio Palumbo
, Gareth John Morgan
, et al.
·
Journal of Clinical Oncology
·
7
Deep and Durable Responses with Weekly Ixazomib, Lenalidomide, and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Long-Term Follow-up of Patients Not Undergoing Stem Cell Transplantation (SCT)
2017
·
Shaji Kumar
, Jesus Berdeja
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
2
Longitudinal Changes in Immune Activation Serum Biomarkers Prior to Diagnosis and Risk of B-cell NHL Subtypes
2022
·
Lynn I. Levin
, Christina M. Ramirez
, et al.
·
Cancer Epidemiology Biomarkers & Prevention
·
1
PDF
Twice-weekly Ixazomib plus Lenalidomide-dexamethasone (Rd) in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Long-term Follow-up Data for Patients Not Undergoing Stem Cell Transplantation (SCT)
2017
·
Paul Richardson
, Craig Hofmeister
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
1
Data from Longitudinal Changes in Immune Activation Serum Biomarkers Prior to Diagnosis and Risk of B-cell NHL Subtypes
2025
·
Lynn I. Levin
, Christina M. Ramirez
, et al.
Figure S1 from Longitudinal Changes in Immune Activation Serum Biomarkers Prior to Diagnosis and Risk of B-cell NHL Subtypes
2025
·
Lynn I. Levin
, Christina M. Ramirez
, et al.
Figure S2 from Longitudinal Changes in Immune Activation Serum Biomarkers Prior to Diagnosis and Risk of B-cell NHL Subtypes
2025
·
Lynn I. Levin
, Christina M. Ramirez
, et al.
Leveraging real-world data to conduct externally controlled trial for rare diseases with count-type endpoints: utilizing multiple entries – a simulation study
2024
·
Tianyu Sun
, Eileen Liao
, et al.
·
Journal of Biopharmaceutical Statistics
Progression And Prognostic Indicators Of Bronchial And Alveolar Disease In Children With Sickle Cell Disease
2012
·
Sophia Williams
, Inderpal Randhawa
, et al.
Challenges in High-throughput Data Analysis: Proteomic Data Pre-processing and Network Methods for Integrating Multiple Data Types
2012
·
Eileen Liao
·
eScholarship (California Digital Library)
PDF
Show more works
View as search
Works count:
28
Citation count:
783
H-index:
13
I10-index:
14
Year
Topic
Type
